Creades AB (0QI9L) DCF Valuation

Creades AB (0QI9.L) تقييم DCF

SE | Financial Services | Financial - Diversified | LSE
Creades AB (0QI9L) DCF Valuation
  • Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • Professional Design: Trusted, Industry-Standard Templates
  • Pre-Built For Quick And Efficient Use
  • No Expertise Is Needed; Easy To Follow

Creades AB (0QI9.L) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Creades AB (0QI9L) with our advanced DCF Calculator! Adjust essential assumptions, explore various scenarios, and evaluate how modifications affect Creades AB (0QI9L) valuation – all within a comprehensive Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 4,014.0 4,473.0 -4,187.0 538.0 1,286.0 1,001.3 779.6 607.0 472.6 367.9
Revenue Growth, % 0 11.43 -193.61 -112.85 139.03 -22.14 -22.14 -22.14 -22.14 -22.14
EBITDA 3,658.0 4,223.0 -3,959.0 524.0 .0 755.9 588.6 458.3 356.8 277.8
EBITDA, % 91.13 94.41 94.55 97.4 0 75.5 75.5 75.5 75.5 75.5
Depreciation -3,498.0 -4,083.0 5,588.0 2.0 .0 -556.8 -433.5 -337.5 -262.8 -204.6
Depreciation, % -87.14 -91.28 -133.46 0.37175 0 -55.61 -55.61 -55.61 -55.61 -55.61
EBIT 7,156.0 8,306.0 -9,547.0 522.0 .0 795.1 619.0 482.0 375.2 292.2
EBIT, % 178.28 185.69 228.02 97.03 0 79.41 79.41 79.41 79.41 79.41
Total Cash 640.0 467.0 613.0 299.0 717.0 246.5 191.9 149.4 116.3 90.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 5.0 .0 .0 3.0
Account Receivables, % 0 0.11178 0 0 0.23328
Inventories 650.0 472.0 .0 .0 .0 53.6 41.7 32.5 25.3 19.7
Inventories, % 16.19 10.55 0 0 0 5.35 5.35 5.35 5.35 5.35
Accounts Payable 44.0 .0 .0 .0 .0 2.2 1.7 1.3 1.0 .8
Accounts Payable, % 1.1 0 0 0 0 0.21923 0.21923 0.21923 0.21923 0.21923
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 0 0 0 0 0 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT 7,138.4 8,254.8 -9,547.0 522.0 .0 793.7 618.0 481.1 374.6 291.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 3,034.4 4,300.8 -3,482.0 524.0 -3.0 187.8 196.0 152.6 118.8 92.5
WACC, % 9.65 9.65 9.65 9.65 9.65 9.65 9.65 9.65 9.65 9.65
PV UFCF
SUM PV UFCF 590.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 94
Terminal Value 1,234
Present Terminal Value 779
Enterprise Value 1,369
Net Debt -717
Equity Value 2,086
Diluted Shares Outstanding, MM 136
Equity Value Per Share 15.37

What You Will Receive

  • Authentic Creades AB Data: Ready-to-use financial metrics – from revenue to EBIT – based on both actual and projected figures.
  • Comprehensive Customization: Modify all key parameters (highlighted in yellow) such as WACC, growth %, and tax rates.
  • Immediate Valuation Adjustments: Automatic updates to analyze the effects of changes on Creades AB’s fair value.
  • Flexible Excel Template: Designed for quick modifications, scenario analysis, and thorough projections.
  • Efficient and Accurate: Avoid the hassle of building models from the ground up while ensuring accuracy and adaptability.

Key Features

  • Pre-Loaded Data: Creades AB's historical financial statements and pre-filled forecasts.
  • Fully Adjustable Inputs: Customize WACC, tax rates, revenue growth, and EBITDA margins.
  • Instant Results: Witness Creades AB's intrinsic value recalculate in real time.
  • Clear Visual Outputs: Dashboard charts showcase valuation results and key metrics.
  • Built for Accuracy: A professional tool designed for analysts, investors, and finance experts.

How It Works

  • 1. Access the Template: Download and open the Excel file featuring Creades AB’s (0QI9L) preloaded data.
  • 2. Modify Assumptions: Adjust essential inputs such as growth rates, WACC, and capital expenditures.
  • 3. See Results Immediately: The DCF model automatically computes intrinsic value and NPV in real-time.
  • 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation possibilities.
  • 5. Present with Confidence: Deliver professional valuation insights to enhance your decision-making process.

Why Opt for This Calculator?

  • User-Friendly Interface: Tailored for both novices and seasoned users.
  • Customizable Inputs: Easily adjust variables to suit your analysis needs.
  • Real-Time Feedback: Observe immediate changes in Creades AB’s valuation as you modify inputs.
  • Preconfigured Data: Comes ready with Creades AB’s actual financial information for swift evaluations.
  • Relied Upon by Experts: Trusted by investors and analysts for making well-informed choices.

Who Can Benefit from This Product?

  • Investment Professionals: Develop comprehensive and accurate valuation models for portfolio assessment.
  • Corporate Finance Departments: Evaluate valuation scenarios to inform internal strategic decisions.
  • Consultants and Advisors: Deliver precise valuation insights for Creades AB (0QI9L) to your clients.
  • Students and Educators: Utilize real-world data to enhance skills in financial modeling and teaching.
  • Tech Aficionados: Gain insights into how technology companies like Creades AB (0QI9L) are evaluated in the market.

Contents of the Template

  • Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Creades AB (0QI9L), including metrics such as revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for the Weighted Average Cost of Capital (WACC), encompassing parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that present intrinsic value along with detailed calculations.
  • Financial Statements: Pre-loaded annual and quarterly financial statements for Creades AB (0QI9L) to facilitate thorough analysis.
  • Key Ratios: Comprehensive profitability, leverage, and efficiency ratios relevant to Creades AB (0QI9L).
  • Dashboard and Charts: A visual representation of valuation outputs and assumptions, designed for straightforward analysis of results.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.